Globus Medical, Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprisin…
Medical - Devices
US, Audubon [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -4.94 | 75.61 | 79.55 | |
| Graham Fair Price | -30.58 | 5.86 | 8.43 | |
| PEG | 1508.48 | 1.71 | 0.11 | |
| Price/Book | -0.24 | 1.83 | 1.84 | |
| Price/Cash Flow | 236.09 | 301.93 | 89.83 | |
| Prices/Earnings | 106.75 | -252.62 | 122.19 | |
| Price/Sales | -0.53 | 11.85 | 11.92 | |
| Price/FCF | 236.09 | 301.93 | 89.83 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -2.87 | 0.55 | 0.57 | |
| Operating Margin | 322.90 | 0.07 | 0.02 | |
| ROA | -51.30 | < 0.005 | < 0.005 | |
| ROE | < 0.005 | < 0.005 | -51.75 | |
| ROIC | < 0.005 | < 0.005 | 472.59 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.01 | < 0.005 | 125.04 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 24.06 | 3.16 | -86.86 | |
| EPS QOQ | 11.50 | -1.48 | -87.15 | |
| FCF QOQ | 1.83 | -0.71 | -61.17 | |
| Revenue QOQ | 0.61 | -0.02 | -97.36 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Bad
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 287.52 | 270.90 | -5.78 | |
| Days Sales Outstanding (DSO) | 73.70 | 79.32 | 7.63 | |
| Inventory Turnover | 0.31 | 0.33 | 6.14 | |
| Debt/Capitalization | 0.10 | 0.12 | 21.93 | |
| Quick Ratio | 2.61 | 1.23 | -52.71 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 29.00 | 28.98 | -0.06 | |
| Cash | 3.76 | 3.21 | -14.53 | |
| Capex | -0.17 | -0.21 | -27.18 | |
| Free Cash Flow | 0.59 | 0.18 | -70.34 | |
| Revenue | 4.47 | 4.48 | 0.24 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad